226 related articles for article (PubMed ID: 21225660)
1. Cytolytic peptide nanoparticles ('NanoBees') for cancer therapy.
Pan H; Soman NR; Schlesinger PH; Lanza GM; Wickline SA
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2011; 3(3):318-27. PubMed ID: 21225660
[TBL] [Abstract][Full Text] [Related]
2. Molecularly targeted nanocarriers deliver the cytolytic peptide melittin specifically to tumor cells in mice, reducing tumor growth.
Soman NR; Baldwin SL; Hu G; Marsh JN; Lanza GM; Heuser JE; Arbeit JM; Wickline SA; Schlesinger PH
J Clin Invest; 2009 Sep; 119(9):2830-42. PubMed ID: 19726870
[TBL] [Abstract][Full Text] [Related]
3. Targeted nanoparticles for head and neck cancers: overview and perspectives.
Zhao Y; Chen H; Chen X; Hollett G; Gu Z; Wu J; Liu X
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Nov; 9(6):. PubMed ID: 28387452
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in melittin-based nanoparticles for antitumor treatment: from mechanisms to targeted delivery strategies.
Yu X; Jia S; Yu S; Chen Y; Zhang C; Chen H; Dai Y
J Nanobiotechnology; 2023 Nov; 21(1):454. PubMed ID: 38017537
[TBL] [Abstract][Full Text] [Related]
5. Dendrimer-based nanocarriers: a versatile platform for drug delivery.
Hsu HJ; Bugno J; Lee SR; Hong S
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Jan; 9(1):. PubMed ID: 27126551
[TBL] [Abstract][Full Text] [Related]
6. Delivery of a Protease-Activated Cytolytic Peptide Prodrug by Perfluorocarbon Nanoparticles.
Jallouk AP; Palekar RU; Marsh JN; Pan H; Pham CT; Schlesinger PH; Wickline SA
Bioconjug Chem; 2015 Aug; 26(8):1640-50. PubMed ID: 26083278
[TBL] [Abstract][Full Text] [Related]
7. Delivery of therapeutics with nanoparticles: what's new in cancer immunotherapy?
Fontana F; Liu D; Hirvonen J; Santos HA
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Jan; 9(1):. PubMed ID: 27470448
[TBL] [Abstract][Full Text] [Related]
8. Development and regulation of exosome-based therapy products.
Batrakova EV; Kim MS
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Sep; 8(5):744-57. PubMed ID: 26888041
[TBL] [Abstract][Full Text] [Related]
9. Multifunctional nanoparticle composites: progress in the use of soft and hard nanoparticles for drug delivery and imaging.
Sangtani A; Nag OK; Field LD; Breger JC; Delehanty JB
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Nov; 9(6):. PubMed ID: 28299903
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and characterization of stable fluorocarbon nanostructures as drug delivery vehicles for cytolytic peptides.
Soman NR; Lanza GM; Heuser JM; Schlesinger PH; Wickline SA
Nano Lett; 2008 Apr; 8(4):1131-6. PubMed ID: 18302330
[TBL] [Abstract][Full Text] [Related]
11. α-Helical coiled-coil peptide materials for biomedical applications.
Wu Y; Collier JH
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Mar; 9(2):. PubMed ID: 27597649
[TBL] [Abstract][Full Text] [Related]
12. Vascular-targeted nanocarriers: design considerations and strategies for successful treatment of atherosclerosis and other vascular diseases.
Kelley WJ; Safari H; Lopez-Cazares G; Eniola-Adefeso O
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Nov; 8(6):909-926. PubMed ID: 27194461
[TBL] [Abstract][Full Text] [Related]
13. Multifunctional platinum-based nanoparticles for biomedical applications.
Cheng Q; Liu Y
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Mar; 9(2):. PubMed ID: 27094725
[TBL] [Abstract][Full Text] [Related]
14. Nanomedicine approaches to improve cancer immunotherapy.
Qiu H; Min Y; Rodgers Z; Zhang L; Wang AZ
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Sep; 9(5):. PubMed ID: 28296286
[TBL] [Abstract][Full Text] [Related]
15. Nanoparticle formulations of cisplatin for cancer therapy.
Duan X; He C; Kron SJ; Lin W
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Sep; 8(5):776-91. PubMed ID: 26848041
[TBL] [Abstract][Full Text] [Related]
16. pH-Sensitive stimulus-responsive nanocarriers for targeted delivery of therapeutic agents.
Karimi M; Eslami M; Sahandi-Zangabad P; Mirab F; Farajisafiloo N; Shafaei Z; Ghosh D; Bozorgomid M; Dashkhaneh F; Hamblin MR
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Sep; 8(5):696-716. PubMed ID: 26762467
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in aliphatic polyesters for drug delivery applications.
Washington KE; Kularatne RN; Karmegam V; Biewer MC; Stefan MC
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Jul; 9(4):. PubMed ID: 27910243
[TBL] [Abstract][Full Text] [Related]
18. Melittin: a lytic peptide with anticancer properties.
Gajski G; Garaj-Vrhovac V
Environ Toxicol Pharmacol; 2013 Sep; 36(2):697-705. PubMed ID: 23892471
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of lytic peptide-bound magnetite nanoparticles in destroying breast cancer cells.
Kumar CS; Leuschner C; Doomes EE; Henry L; Juban M; Hormes J
J Nanosci Nanotechnol; 2004 Mar; 4(3):245-9. PubMed ID: 15233083
[TBL] [Abstract][Full Text] [Related]
20. Turning Toxicants into Safe Therapeutic Drugs: Cytolytic Peptide-Photosensitizer Assemblies for Optimized In Vivo Delivery of Melittin.
Jia HR; Zhu YX; Xu KF; Wu FG
Adv Healthc Mater; 2018 Aug; 7(16):e1800380. PubMed ID: 29931753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
